News Releases and Announcements

Enter a Year (YYYY)
United States Pharmacopeia Statement: Angels for Change, USP and Vizient collaborate to characterize and quantify supply chain risk for drugs to improve pediatric oncology patient access to quality medicines
May 13, 2021
Phlow Corp. and USP announce strategic alliance focused on Pharmaceutical Continuous Manufacturing to increase supply of essential medicines for U.S. patients
February 22, 2021
U.S. Pharmacopeia (USP) expands alcohol-based hand sanitizer support in response to quality incidents reported during the COVID-19 pandemic
February 3, 2021
USP applauds Biden administration executive actions on supply chain
January 22, 2021
Healthcare Groups Release Proceedings of Summit Exploring Drug Safety, Supply Chain Security
December 22, 2020
Krishna Reddy Nallamalla, M.D., named to USP Board of Trustees
December 16, 2020
John Taylor, J.D., named to USP Board of Trustees
December 16, 2020
Laura Herman, M.B.A., M.A., named to USP Board of Trustees
December 16, 2020
USP launches COVID-19 vaccine survey of frontline healthcare workers in low- and middle- income countries, with support from George Mason University
October 28, 2020
USP and DFAT Partner to Strengthen Laboratories and Improve Medicines Quality in Cambodia and Laos
September 30, 2020
USP partners with the Republic of Korea on laboratory testing of USP Reference Standard candidate materials
August 6, 2020
Drug Safety Summit examined national security implications of global drug manufacturing
August 4, 2020
USP and International Association for Pharmaceutical Technology (APV) Present Four-Day Series on Quality of 3D Printing of Medicines and Supplements July 13-16
July 14, 2020
USP launches new standards, tools for detecting and controlling nitrosamine impurities in drug supply chain
July 9, 2020
USP announces newly elected Board of Trustees for the 2020-2025 cycle
June 25, 2020
USP hosts virtual roundtable on biologics nomenclature proposal
June 24, 2020
Stakeholders’ Views on the Current State of Excipient Innovation
June 24, 2020
USP releases three new monoclonal antibody Reference Standards that support development of critical COVID-19 treatments
June 15, 2020
Reducing barriers to quality medicines
June 1, 2020
USP provides guidelines for Recombinant Factor C (rFC) a non-animal-derived reagent critical to development of vaccines and other sterile pharmaceutical products
May 29, 2020
100+ Experts Identified Top Threats and Opportunities for Global Health Just Before COVID-19 Emerged as the First Test of the Medicines Supply Chain
May 21, 2020
USP Statement to the 73rd World Health Assembly Agenda Item 3: Address by WHO Director-General, devoted to the COVID-19 pandemic response
May 18, 2020
USP launches Trust Accelerated Program to help speed development of quality COVID-19 treatments and vaccines
May 11, 2020
The quality of botanical dietary supplements: past, present and future
May 4, 2020
U.S. Pharmacopeia (USP) outlines plans that support the quality of cannabis for medical use
April 17, 2020